Synopsis
This educational presentation will summarize the imaging tools to study the brain of preterm infants, detect brain injury and predict neurodevelopment outcomeIntroduction
Neurodevelopmental disabilities observed in preterm
infants encompass a wide spectrum of deficits, ranging from motor and cognitive
deficits, to behavioral and psychological problems.These
morbidities have important public health, economic, societal implications
worldwide.
In order to best target interventions to prevent and/or treat these adverse
neurodevelopmental sequelae in those at risk and most vulnerable, clinicians must be able to better
identify high-risk preterm infants and better prognosticate neurodevelopmental
outcomes using the clinical tools available.
There have been significant
advances in MRI technology, but even with improvements in the field of
neuroimaging with MR, there have been many challenges to its use in the
neonatal population. Some of the
practical barriers to its use in the neonatal population have been cost of MRI,
equipment compatibility with the magnet, perception of the need for sedation,
as well as general accessibility issues when compared to bedside cUS, including
transport to MRI and the overall stability of critically ill neonates to leave
the neonatal intensive care unit. However, with the development of
MR-compatible incubators, imaging of the more critical neonates can be done in
a safe, thermo-regulated, and appropriate environment with continuous
cardiorespiratory monitoring.
This presentation addresses the role of magnetic resonance (MR)
imaging (MRI) in the prediction of neurodevelopmental outcomes in preterm
infants and explores the usefulness of state-of-the-art MR strategies to better
understand the preterm infants encephalopathy.
MRI and Neurodevelopmental Outcomes
Although
it has been shown that MRI provides more comprehensive information of the
neonatal brain structure, including more subtle abnormalities unable to be
detected on cUS, the clinical implications of these findings require standardization,
validation and long term follow-up.
There have been numerous studies that have evaluated the ability of MRI at
term equivalent age to predict neurodevelopmental outcomes at 12 months to 9
years.
The
studies with more recent cohorts, large sample sizes and quantitative
predictive data are summarized in Table 2.
White Matter Abnormalities
The most extensively studied MRI
abnormality shown to predict neurodevelopmental outcomes is white matter
lesions. Types of white matter
abnormalities have included periventricular leukomalacia, punctate white matter
lesions (PWML), and Diffuse Excessive High Signal Intensities (DEHSI). The etiology of these entities has yet to be
completely understood. Specifically in
regards to PVL and PWML, it is unclear if they represent a spectrum of one
disorder or separate entities with different etiologies, but they both
correlate with long-term neurodevelopmental outcomes. In contrast, DEHSI has been shown in numerous
studies to not correlate with long-term outcomes.2
Periventricular leukomalacia is a
form of white matter injury, which is focal and cystic. It is histologically characterized by
coagulative necrosis within the subventricular lamina of the periventricular
white matter, leading to the destruction of cellular elements and the formation
of cysts, and possibly secondary ventriculomegaly
Punctate white
matter lesions are non-specific focal lesions in the white matter on MRI that
are also commonly found in preterm infants.
They are represented as increased signal on T1-weighted imaging and
decreased signal on T2-weighted imaging and may histologically reflect
petechial hemorrhages, gliotic scarring, or mineralization. Diffuse excessive
high signal intensities (DEHSI) are a frequent finding on T2-weighted MR images
near-term in children born prematurely3
– seen in up to 80% of preterm infants at term equivalent age.4,5
They are hyperintense white matter signal abnormalities found in the periventricular
and subcortical white matter regions when compared to the signal intensity of normal unmyelinated white
matter.
The most common outcome measure in studies that look
to correlate MRI findings and neurodevelopment outcomes is motor dysfunction,
ranging from mild motor delay to severe cerebral palsy. Although the ability of MRI to predict
cerebral palsy can be variable, one of the most important observations from past
studies is that preterm children without white matter abnormalities on term MRI
did not show significant neurodevelopmental deficits compared to full term
controls – specifically in regards to motor 6 cognitif and executive
functioning 7,8 demonstrating that MRI has a high negative
predictive value.
Compared
to infants born at term, preterm infants though have been shown to have
cognitive impairments, requiring special assistance at school. White matter abnormalities have been shown in
studies to be associated with lower cognition, language abilities, and
executive functioning.
Gray Matter Abnormalities
Gray matter can be assessed for both morphology,
including cortical folding and surface area, as well as signal abnormalities. Gray matter abnormalities (assessed by size
of the subarachnoid space, quality of gyral maturation and presence of gray
matter cortical signal abnormality) are also associated with poorer
neurodevelopment outcome.
Cerebellar Abnormalities
Cerebellar abnormalities have been described as
destructive lesions vs. those representing impaired development. Destructive lesions include cerebellar
hemorrhage and infarction. Cerebellar
hemorrhage is usually unilateral and associated with supratentorial lesions,
leading to possible cerebellar atrophy with time 9 which is related to neurodevelopmental sequelae.33
Classification of qualitative MRI in the preterm infant
There have been different classification
systems proposed and used for the interpretation of MRI data defining MR
abnormalities and relate them to neurodevelopmental outcome (refer to Table 3)
Woodward
et al described and used a comprehensive scoring system to define brain
abnormalities in preterm infants near term age ..11,12 A
separate scoring system was used to define the extent of gray matter (GM)
injuries. Moderate-to-severe cerebral white-matter
abnormalities were predictive of cognitive delay with odds ratio (OR) of 3.6,
motor delay with an OR of 10.3, and CP with an OR of 9.6. The OR of gray matter abnormalities in
association with severe cognitive delay or CP ranged from 2-3.11
This scoring system has been further refined by Kidikoro et al.13{These scoring
systems offer a more objective and comprehensive method to classify magnitude
of brain injury in the preterm population given the wide range of complex MRI
abnormalities associated with prematurity, as well as predict
neurodevelopmental outcomes. In recent
neuroprotective drug trials these methods have helped to monitor drug intervention
effects 14
Timing
of MRI
Both qualitative and
quantitative MR techniques have been used to assess the preterm brain at
different stages in development, including in the perinatal period, at term
equivalent age, and through childhood into adolescence. Compared to the MRI at time of birth, the MRI
at term equivalent age still remains the optimal scanning time for children
born prematurely in the prediction of neurodevelopmental outcomes, given the
greater clinical stability of the population at term as well as the success of
feed and wrap protocols in obviating the need for sedation. In addition, the most commonly studied timing
of MRI scans in the preterm population to predict neurodevelopmental outcomes
is term equivalent age. However, there
have been some studies investigating the correlation between serial MR imaging
and neurodevelopmental outcomes, looking at changes in findings over time.
PROMISING NEW MRI STRATEGIES
The development of sophisticated new MRI strategies has permitted a better
understanding of corticogenesis in the prematurely born. Furthermore, data from many of these
strategies, including volumetric imaging, diffusion tensor imaging, MRS and
functional connectivity, has been shown to correlate with cognitive measures in
preterm subjects at school age, adolescence and young adulthood.
Below
we describe these strategies, and the published neonatal outcome data
available. Although these studies do not represent the predictive utility of
volumetric MRI in terms of PPV/NPV or sensitivity/specificity, the outcome data
generated from each is presented in Table 4.
Volumetric
Imaging
Volumetric analysis uses two
or three-dimensional MR images to quantitatively characterize alterations of
brain development associated with prematurity and brain injury. It allows for the measurement of volume of
specific brain structures including
the cortical and subcortical regions, cerebellum and hippocampus. Automated
segmentation techniques can be used to differentiate grey matter and white
matter as well as unmyelinated and myelinated tissue.15
Volume reduction in the
whole brain, anatomic structures in the brain, and regionally within white
matter and cortical grey matter have been reported in preterm infantsIn
addition, simple brain metric measurements using MRI as a method to assess
brain growth and atrophy in the neonates has been shown to correlate with
outcome
Smaller brain volume at
term equivalent age, when correcting for effects of white matter injury, is
correlated with subsequent performance on object
working memory tasks in infancy.16
Subsequent working memory performance in
infancy was also shown to be associated with reductions in volumes of
dorsolateral prefrontal, sensory, motor, parieto-occipital and premotor cortex.16
Total white matter volumes in sensory, motor and mid-temporal regions at term
equivalent age are strong predictors of neurodevelopmental outcome in the first
year of life.17
Inder et al18
showed that the overall gray matter volume at term is predictive of
neurodevelopmental outcome, while Boardman showed association between decreased
volumes of deep gray matter and neurocognitive outcome.19
Diffusion Tensor Imaging
Assessing
the microstructural development of the white and gray matter in prematurely
born infants has become feasible with the recent advantages in diffusion
imaging. Inferring information about the underlying tissue microstructure from
dMRI is an inverse problem, were models of different complexity are fitted to
the acquired signal . The most popular model to describe changes in the dMRI signal
intensities is the diffusion tensor model (DTI). In this model, the directional
motion of water behavior is characterized by a 3 dimensional tensor. Diffusion
tensor imaging measures relies on the water motion providing the useful
parameters for describing the underlying microstructure. Measure
of fractional anisotropy (FA) describes the degree to which water diffusion is
restricted in one direction relative to all others.
FA
values of major white matter tracts were correlated with gross and fine motor
performance. Lower FA in regions of corpus callosum, at term
equivalent age, was shown to correlate with the psychomotor developmental index
Furthermore, the lower values of FA at
term in posterior limb of internal capsule were associated with
neurodevelopmental outcomes in first year of life. Follow-up of children with abnormal
neurological exams in the first year of life showed decreased FA values in
posterior limb of the internal capsule at term age when measured
retrospectively. In recent years DTI has been extended to use multiple gradient
directions to assess better the directionality of water diffusion in crossing fibers
and multiple b-values to assess diffusion characteristics in tissue
compartments defined by biophysical models such as NODDI
fMRI
Functional MRI uses deoxygenated hemoglobin in
the body as an endogenous contrast agent to produce a BOLD (blood-oxygenation-level-dependent) signal. This signal detects regional changes in
hemodynamics of the brain that are correlated with functional activity. By utilizing these BOLD
signals in neonates, it is possible to identify networks with synchronous
neuronal activity in sleeping neonates to study resting state functional
connectivity throughout development.
Born
et al was the first to use fMRI to show
brain activation using visual stimulation in healthy newborns 22 and since then multiple
studies have investigated the correlation between passive functions with fMRI
as a clinical tool to evaluate the sensorimotor, visual and auditory systems in
infants with brain injury. 23 The prognostic
implications of these findings have still yet to be determined and further
research in the use of functional MRI in the preterm population may contribute
to the predictive abilities of long-term neurodevelopmental outcomes in the
preterm population.
MRS
Magnetic resonance
spectroscopy (MRS) is a noninvasive measure of brain biochemistry. MRS provides information regarding provides
information about common metabolites found in the brain such as
N-acetyl-aspartate (NAA), choline-containing compounds (Cho), creatine and
lactate which are involved in cellular metabolic pathways. NAA is present in axons and
considered to be a marker for neurons. It
has been found to increase with advancing gestational age and maturity.24 Choline containing compounds are involved in
ATP synthesis. Creatine is thought to be
related to membrane metabolism. Lactate,
though may be a marker for impaired metabolism from decreased cerebral blood flow
in term neonates with hypoxic ischemic injury,25 elevations may be
normal in preterm infants due to differences in metabolism.26
CONCLUSIONS
MRI is a non-invasive mode
of neuroimaging that is superior to ultrasound and currently the best whole
brain imaging tool available for the newborn. It has
great potential for clinical use in characterizing the extent of preterm brain
injury in neonates and predicting neurodevelopmental outcomes. In regards to
advanced MRI modalities, additional research is needed to prove clinical
utility, but holds promise. With the
combination of conventional and advanced MR imaging techniques, we hope to be
able to attain a more comprehensive view of the preterm brain – including both
macrostructural and microstructural changes to better predict those at highest
risk of impairment, as well as precisely define the type and extent of deficits
likely to develop in the future and use the imaging tool to monitor effects of
therapeutic interventions.
Acknowledgements
Modified from Kwong, Vassung, Ment, Hüppi et al Clinics in Perinatology
Tables reproduced with permission
References
1. Larroque
B, Ancel PY, Marret S, et al. Neurodevelopmental disabilities and special care
of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a
longitudinal cohort study. Lancet 2008;371:813.
2. Kidokoro
H, Anderson PJ, Doyle LW, Neil JJ, Inder TE. High signal intensity on
T2-weighted MR imaging at term-equivalent age in preterm infants does not
predict 2-year neurodevelopmental outcomes. AJNR Am J Neuroradiol
2011;32:2005-10.
3. Maalouf
EF, Duggan PJ, Rutherford MA, et al. Magnetic resonance imaging of the brain in
a cohort of extremely preterm infants 8. JPediatr 1999;135:351.
4. Dyet
LE, Kennea N, Counsell SJ, et al. Natural history of brain lesions in extremely
preterm infants studied with serial magnetic resonance imaging from birth and
neurodevelopmental assessment. Pediatrics 2006;118:536.
5. Huang
H, Jeon T, Sedmak G, et al. Coupling Diffusion Imaging with Histological and
Gene Expression Analysis to Examine the Dynamics of Cortical Areas across the
Fetal Period of Human Brain Development. CerebCortex.
6. Setanen
S, Haataja L, Parkkola R, Lind A, Lehtonen L. Predictive value of neonatal
brain MRI on the neurodevelopmental outcome of preterm infants by 5 years of
age. Acta Paediatr 2013;102:492-7.
7. Woodward
LJ, Clark CA, Bora S, Inder TE. Neonatal white matter abnormalities an
important predictor of neurocognitive outcome for very preterm children. PLoS
One 2012;7:e51879.
8. Woodward
LJ, Clark CA, Pritchard VE, Anderson PJ, Inder TE. Neonatal white matter
abnormalities predict global executive function impairment in children born
very preterm. Dev Neuropsychol 2011;36:22-41.
9. Volpe
JJ. Cerebellum of the premature infant: rapidly developing, vulnerable,
clinically important. JChild Neurol 2009;24:1085.
10. Miller
SP, Ferriero DM, Leonard C, et al. Early brain injury in premature newborns
detected with magnetic resonance imaging is associated with adverse early
neurodevelopmental outcome. JPediatr 2005;147:609.
11. Woodward
LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict
neurodevelopmental outcomes in preterm infants. NEnglJMed 2006;355:685.
12. Inder
TE, Wells SJ, Mogridge NB, Spencer C, Volpe JJ. Defining the nature of the
cerebral abnormalities in the premature infant: a qualitative magnetic
resonance imaging study 2. JPediatr 2003;143:171.
13. Kidokoro
H, Neil JJ, Inder TE. New MR imaging assessment tool to define brain
abnormalities in very preterm infants at term. AJNR Am J Neuroradiol
2013;34:2208-14.
14. Leuchter
RH, Gui L, Poncet A, et al. Association between early administration of
high-dose erythropoietin in preterm infants and brain MRI abnormality at
term-equivalent age. JAMA 2014;312:817-24.
15. Dubois
J, Benders M, Cachia A, et al. Mapping the early cortical folding process in
the preterm newborn brain. Cereb Cortex 2008;18:1444-54.
16. Huppi
PS, Maier SE, Peled S, et al. Microstructural development of human newborn
cerebral white matter assessed in vivo by diffusion tensor magnetic resonance
imaging. Pediatr Res 1998;44:584-90.
17. Woodward
LJ, Edgin JO, Thompson D, Inder TE. Object working memory deficits predicted by
early brain injury and development in the preterm infant. Brain 2005;128:2578.
18. Peterson
BS, Anderson AW, Ehrenkranz R, et al. Regional brain volumes and their later
neurodevelopmental correlates in term and preterm infants. Pediatrics
2003;111:939.
19. Inder
TE, Warfield SK, Wang H, Huppi PS, Volpe JJ. Abnormal cerebral structure is
present at term in premature infants 4. Pediatrics 2005;115:286.
20. Boardman
JP, Craven C, Valappil S, et al. A common neonatal image phenotype predicts
adverse neurodevelopmental outcome in children born preterm. Neuroimage;52:409.
21. Kunz N,
Zhang H, Vasung L, et al. Assessing white matter microstructure of the newborn
with multi-shell diffusion MRI and biophysical compartment models. Neuroimage
2014;96:288-99.
22. Born P,
Rostrup E, Larsson HB, Leth H, al e. Changing Pattern of visually induced fMRI
response during human development. 1996;
New York. p. 1860.
23. Seghier
ML, Huppi PS. The role of functional magnetic resonance imaging in the study of
brain development, injury, and recovery in the newborn. Semin Perinatol
2010;34:79-86.
24. Kreis
R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Huppi PS. Brain metabolite
composition during early human brain development as measured by quantitative in
vivo 1H magnetic resonance spectroscopy. Magn ResonMed 2002;48:949.
25. Miller
SP, Newton N, Ferriero DM, et al. Predictors of 30-month outcome after
perinatal depression: role of proton MRS and socioeconomic factors. PediatrRes
2002;52:71.
26. Leth H,
Toft PB, Pryds O, Peitersen B, Lou HC, Henriksen O. Brain lactate in preterm
and growth-retarded neonates. Acta Paediatr 1995;84:495.
27. Rutherford
M, Srinivasan L, Dyet L, et al. Magnetic resonance imaging in perinatal brain
injury: clinical presentation, lesions and outcome. PediatrRadiol 2006;36:582.
28. Beaulieu
C, Plewes C, Paulson LA, et al. Imaging brain connectivity in children with
diverse reading ability. Neuroimage 2005;25:1266.
29. Dudink
J, Lequin M, van PC, et al. Fractional anisotropy in white matter tracts of
very-low-birth-weight infants. PediatrRadiol 2007;37:1216.
30. Mukherjee
P, McKinstry RC. Diffusion tensor imaging and tractography of human brain
development. Neuroimaging ClinNAm 2006;16:19.
31. Wimberger
DM, Roberts TP, Barkovich AJ, Prayer LM, Moseley ME, Kucharczyk J.
Identification of "premyelination" by diffusion-weighted MRI.
JComptrAssisted Tomography 1995;19:28.
32. Ment
LR, Hirtz D, Huppi PS. Imaging biomarkers of outcome in the developing preterm
brain. Lancet Neurol 2009;8:1042-55.